OSUR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OSUR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
OraSure Technologies's Current Accrued Expense for the quarter that ended in Mar. 2024 was $7.5 Mil.
OraSure Technologies's quarterly Current Accrued Expense increased from Sep. 2023 ($14.9 Mil) to Dec. 2023 ($17.5 Mil) but then declined from Dec. 2023 ($17.5 Mil) to Mar. 2024 ($7.5 Mil).
OraSure Technologies's annual Current Accrued Expense declined from Dec. 2021 ($27.0 Mil) to Dec. 2022 ($18.8 Mil) and declined from Dec. 2022 ($18.8 Mil) to Dec. 2023 ($17.5 Mil).
The historical data trend for OraSure Technologies's Current Accrued Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Current Accrued Expense | Get a 7-Day Free Trial | 8.86 | 15.75 | 27.01 | 18.79 | 17.48 |
OraSure Technologies Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Current Accrued Expense | Get a 7-Day Free Trial | 15.97 | 18.07 | 14.94 | 17.48 | 7.46 |
Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.
Thank you for viewing the detailed overview of OraSure Technologies's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
Kathleen Gallagher Weber | officer: Chief Product Officer | 220 EAST FIRST STREET, BETHLEHEM PA 18017 |
Michele Marie Miller | officer: VP, Finance and Controller | 220 EAST FIRST STREET, BETHLEHEM PA 18017 |
Robert W. Mcmahon | director | 250 CAMPUS DRIVE, MARLBOROUGH MA 01752 |
Kenneth J Mcgrath | officer: Chief Financial Officer | C/O ORASURE TECHNOLOGIES, INC., 220 E. FIRST STREET, BETHLEHEM PA 18015 |
Ronny B Lancaster | director | ORASURE TECHNOLOGIES INC, 220 EAST FIRST STREET, BETHLEHEM PA 18015 |
Mara G. Aspinall | director | 7381 NORTH MOON SPIRIT LANE, TUCSON AZ 85718 |
Nancy J Gagliano | director | 33 GRANITE WAY, GRANTHAM NH 03753 |
Michael Celano | director | 220 EAST FIRST STREET, BETHLEHEM PA 18015 |
Manner Carrie Eglinton | director, officer: President & CEO | C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094 |
Scott Gleason | officer: Interim CFO/SVP IR | 1809 SOUTH 2500 EAST, SALT LAKE CITY UT 84108 |
Eamonn P Hobbs | director | C/O DELCATH SYSTEMS, INC., 600 FIFTH AVENUE, NEW YORK NY 10020 |
Anne Clem Whitaker | director | 109 BRIERY BRANCH COURT, MORRISVILLE NC 27560 |
James A Datin | director | 21 ESTATES DRIVE, DOYLESTOWN PA 18901 |
Lelio Marmora | director | 64 RUE DE VESENEX, DIVONNE LES BAINS I0 01220 |
Lisa Nibauer | officer: President of Diagnostics | 1 CRESENT PLACE, SHORT HILLS NJ 07078 |
From GuruFocus
By sperokesalga sperokesalga • 05-03-2023
By GuruFocusNews GuruFocusNews • 06-22-2022
By Stock market mentor Stock market mentor • 02-07-2023
By Value_Insider Value_Insider • 11-01-2022
By GuruFocusNews GuruFocusNews • 07-06-2022
By GuruFocusNews GuruFocusNews • 07-02-2022
By GuruFocus Research • 11-07-2023
By Value_Insider Value_Insider • 11-03-2022
By PurpleRose PurpleRose • 07-14-2022
By GuruFocusNews GuruFocusNews • 06-28-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.